Several colleagues from the Kirk Kerkorian School of Medicine at UNLV published "Clinical Characteristics and Implications of Bradycardia in COVID‑19 Patients Treated with Remdesivir: A Single‑Center Retrospective Cohort Study" in the journal Clinical Drug Investigation. The results of the study highlight the need to evaluate the cardiac-related adverse events of remdesivir treatment.
